University of Exeter partners with mHealth provider Monsenso in dementia research project.

University of Exeter partners with mHealth provider Monsenso in dementia research project.

Copenhagen, Denmark – 25 March 2019. The University of Exeter, supported by the South West Academic Health Science Network, has partnered with Danish mobile health provider Monsenso in ‘The MOVE Study’ (formerly known as The Klick Project), a research project that aims to review how the Monsenso Solution can be used to support individuals to engage in healthy behaviours that could make a difference to their risk of getting dementia. The Monsenso Solution is a mobile platform, where the individual is prompted with daily self-assessments, weekly clinical scales, while sensor data is collected via the phone. Moreover, it connects the individual and clinician, visualising individual-reported data for both parties and facilitates the possibility of providing patients with relevant information to handle specific challenges that may impact their wellbeing.

Both from a societal and a clinical standpoint, the burden of dementia is a growing challenge. The number of people affected by dementia worldwide will reach 75 million people in 2030. In the UK, for example, Dementia UK estimated that approximately 850,000 people were living with dementia[1]. In addition, it was estimated that one in three people born in 2015 will develop dementia in their lifetime[2]. Therefore, new ways of tackling this challenge must be found.

In collaboration with Monsenso, the lead researchers on The MOVE Study – Dr Barbora Silarova and Dr Rachel Collins will set up the solution to support The MOVE Study, and hereafter demonstrate its capabilities for clinicians and patients and receive their feedback. The findings will be used to guide development of future intervention that focuses on changing healthy behaviours that could make a difference to people’s risk of getting dementia. It is planned for the intervention to be delivered in primary care. The configuration of the Monsenso Solution for The MOVE Study will include one of the newest additions to the system; an integration to Withings (wearable technology) which allows for collection of sensor data, such as physical activity, sleep and pulse.

Thomas Lethenborg, CEO of Monsenso, says: “Dementia is a huge challenge for society to overcome, and it will be growing in the coming years due to an ageing population. We are looking forward to testing whether our solution can help people to engage in healthy behaviours to live a healthy life. We may draw on experiences gained from the H2020 funded WellCo project, which aims at improving the well-being of elderly people.”

About University of Exeter

University of Exeter combines teaching excellence and high levels of student satisfaction with world class research at their campuses in Devon and Cornwall. They are part of the Russell Group as one of the 24 leading UK universities. Their success is built on a strong partnership with their students and a clear focus on high performance.

For more information about dementia research conducted at University of Exeter, please see http://www.exeter.ac.uk/dementia/.

About South West Academic Health Science Network

The South West Academic Health Science Network (SW AHSN) works to improve the health and patient experience of people in the South West by supporting and accelerating innovation and quality improvement. SW AHSN is part of a national network of 15 AHSNs set up by NHS England, to identify, adopt and disseminate innovative healthcare. As part of KLICK, they will be aiding in the conversation and co-design of solutions to better meet patient needs by bringing together innovators and adopters of new ideas for health and social care.

To learn more, visit https://www.swahsn.com/.

About Monsenso

Monsenso is an innovative technology company offering a mHealth solution that optimises the treatment of mental disorders. The smartphone-based solution gives a detailed overview of an individual’s mental health through the collection of outcome, adherence and behavioural data, and it connects individuals, carers and health care providers enabling personalised treatment, remote care and early intervention.

To learn more, visit www.monsenso.com

For more information about Monsenso contact:

Thomas Lethenborg
CEO
Monsenso 
+45 21298827
lethenborg@monsenso.com


[1] Dowrick, A., Southern, A. . Dementia 2014: Opportunity for change. 2014  17/10/2018]; Available from: https://www.alzheimers.org.uk/sites/default/files/migrate/downloads/dementia_2014_opportunity_for_change.pdf.

[2] Lee, V.S., J. Simpson, and K. Froggatt, A narrative exploration of older people’s transitions into residential care. Aging Ment Health, 2013. 17(1): p. 48-56.

Improve the way you work with your mental health patients

Improve the way you work with your mental health patients

Copenhagen, Denmark – 28 February 2019. Mobile health technology can be used to support important decision making in diagnosis and treatment, especially in the field of mental health. It can empower patients by involving them in their own treatment and by providing them with the tools needed to help them manage their own disorder. Monsenso is leading the way in making technology an integral and useful part of mental health treatment.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Imagine a session with your patient in which you have an overall picture of their mood, sleep, and medication adherence and can ask questions relating to their current mental state.  You can view patient self-assessment data that will give you a better idea of how they have been doing day-to-day, giving you a better understanding of their mood over time. With this, your questions in the session can be more relevant, and you can more quickly identify important topics.

What you just read is a possibility when taking advantage of today’s technology. In the Monsenso app, patients are asked to fill out a quick, daily self-assessment or weekly questionnaires. They may for instance be asked to rate their sleep, mood or activity. They will be able to follow their own progress and become more aware of how the choices they make impact their mental state. What is more is that you can see exactly what your patients input through accessing the clinical web-portal. This knowledge can help you in the process of diagnosing or finding the most effective medication for an individual more quickly. Clinicians using the system say that the solution can be compared to a “mental X-ray,” which may even allow you to do early interventions, as you can see which patients are beginning to experience a negative state or even a relapse.

One healthcare professional who uses the Monsenso solution says: “During conversations with my patients, I always start with the data in the system. It is a great icebreaker that allows me to skip asking certain questions. Now, our conversations are facilitated by the information available in the system.”

The Monsenso solution empowers patients to be more involved in their own treatment. In between sessions they may use relevant features when they are facing a challenging situation, whether it is restructuring negative thoughts using our mobile CBT thought feature or learning more about their disorder or treatment plan in the psychoeducation library.

A patient living with bipolar disorder finds the solution beneficial in managing their disorder: “It made me more aware of how my sleep pattern influences my mood. In my life with this disorder I see myself as a tightrope walker, and this metaphor for living with bipolar disorder is very meaningful. You have to prevent losing control either to depression or to mania. You are able to avoid that by earlier registration on how your mood is fluctuating, so therefore the app helps to keep you in control of your life…”

We believe it is time for technology to ease the burden on clinicians and provide opportunities that are not available when everything is handled in the old paper-pencil way. If you too think technology needs to become more widely used in the treatment and is ready to embrace it, Monsenso will be there helping you all the way.

Want to know more? You are more than welcome to visit www.monsenso.com, or e-mail any questions to mankhong@monsenso.com.

Leading Danish addiction treatment center, KABS, enhances treatment services with data-driven mobile health technology

Leading Danish addiction treatment center, KABS, enhances treatment services with data-driven mobile health technology

Copenhagen, Denmark – 30 January 2019. The management of Copenhagen-based KABS acknowledges that there is a need to digitise parts of the treatment to both ease the burden of difficult and time consuming data collection and to offer people better, more proactive and personalised treatment. Therefore, Monsenso and KABS have joined forces to provide more effective, user-centered treatment by using mobile health technology to better support people struggling with addiction.

“Knowing about the individual’s well-being is crucial for setting up the best possible treatment. Gathering data solely through face-to-face interviews might often be inaccurate and time consuming, and the data may be biased by the individuals’ well-being and motivations during each interview session. We have decided to use the Monsenso solution, to improve our data collection using a digital platform for individuals to do self-assessments. By knowing more about the individuals, we are able to provide better treatment, while it is also an attempt to reach and attract the young people, who are in need of help.” says Rasmus Axelsson, Head of KABS.

The Monsenso solution will be implemented in a pilot project in the unit KABS Stjernevang with 10 therapists using the system. The pilot project includes both alcohol and substance abuse, as well as cases of comorbidity, where individuals also suffer from a mental illness. The mHealth solution combines data collection through self-assessments and questionnaires to provide the therapists with a detailed longitudinal view of the person’s wellbeing.

The Monsenso solution will be customised to complement KABS’ services in order to provide therapists with an overview of the individual’s illness progression, their symptoms and any medication compliance. The solution also notifies therapists and users when they display any illness related warning signs, enabling them to monitor each user remotely and to intervene at an early stage.

“We are looking forward to be working with KABS and the experienced team of therapists. We understand the very close relationship between mental health and addiction and are working closely with Rasmus and his Team to enhance the way alcohol and substance abuse treatment is delivered.” said Thomas Lethenborg, CEO of Monsenso.

Click here to read the press release in Danish.

About KABS

KABS is part of Glostrup Municipality and is one of the largest addiction treatment centers in Denmark, and has provided medical treatment and therapy for substance and alcohol abuse for many years. The organisation currently provides medical and social treatment for substance and alcohol abuse to approximately 800 citizens from 46 municipalities.

To learn more, visit https://www.kabs.dk/

About Monsenso

Monsenso is an innovative technology company offering a mHealth solution that optimises the treatment of mental disorders. The smartphone-based solution gives a detailed overview of an individual’s mental health through the collection of outcome, adherence and behavioural data, and it connects individuals, carers and health care providers enabling personalised treatment, remote care and early intervention.

To learn more, visit www.monsenso.com

For more information about Monsenso contact:

Thomas Lethenborg
CEO
Monsenso
+45 21298827
lethenborg@monsenso.com

Jeg tror virkelig at Monsenso kan hjælp andre med bipolar type 2

Jeg tror virkelig at Monsenso kan hjælp andre med bipolar type 2

Watch Peter Hagelund’s documentary series, ‘Jeg savner min sygdom’  on living with bipolar disorder type 2 here.

For fire år siden blev jeg diagnosticeret med bipolar lidelse type 2.

I hele mit liv har jeg vidst, at jeg var anderledes. Jeg har altid kæmpet med depression og angst, og hvad der viste sig at være hypomani. Da jeg var 22, havde jeg min første slemme depressive episode, og jeg blev nødt til at starte på antidepressiver. Alligevel tog det yderligere 6 år, før jeg officielt blev diagnosticeret med bipolar lidelse type 2.

Det sværeste, ved at have diagnosen bipolar lidelse type 2, er at man ikke oplever den typiske maniske episode, hvor man er over-energisk og på grænsen til psykotisk. I stedet er man hypomanisk, som betyder at man er socialt velfungerende. Man er ikke psykotisk. Man føler sig faktisk rigtig godt tilpas. Så problemet er, at man ikke ender med at tage til sin psykiater og sige, at man føler sig for godt tilpas. Det gjorde jeg i hvert fald ikke!

Årsagen til at min psykiater fandt ud af, at jeg var bipolar, skyldtes at han ikke kunne få mig ud af mine depressioner. Først diagnosticerede han mig med depression og ADD. Men disse diagnoser var ikke rigtige. Da jeg ikke havde den rette diagnose, fik jeg stadig mine store humørsvingninger og meget angst. Da jeg så blev diagnosticeret med den ’rigtige’ diagnose, bipolar lidelse type 2, føltes det faktisk rigtig godt. En masse ting gav mening. Pludselig kunne jeg se, hvorfor jeg havde følt, som jeg havde hele mit liv.

Jeg tror virkelig, at Monsenso kunne have hjulpet min psykiater med at diagnosticere min lidelse tidligere, fordi app’en hjælper mig med at tracke mit stemningsleje og med at blive mereopmærksom på, hvordan jeg har det. På grund af app’en skal jeg hver dag tage en pause og tænke på, hvordan jeg egentlig har haft det, før jeg taster svaret ind. Når jeg tager til psykiater, kan vi sammen se, hvordan jeg har haft det. En god ting ved app’en er, at mit svar ikke afhænger af min hukommelse, men af hvad jeg faktisk svarede den pågældende dag. At indsamle al den her information kan hjælpe mig, og derved min psykiater, præventativt med at undgå fremtidige depressive eller hypomaniske episoder, fordi vi tydeligt kan identificere, når jeg har humørsvingninger.

I august har min dokumentar, om at være bipolar, premiere på nationalt fjernsyn. Reaktionerne har været overvældende. Rigtig mange personer har skrevet til mig og takket mig for at snakke om sygdommen. Jeg havde oprindeligt tænkt mig, at lave dokumentaren således, at ingen personer ville blive flove over at have sygdommen. Jeg tror, det er lykkedes mig.

Mit håb for fremtiden er, at personer bliver diagnosticeret med lidelsen tidligere end jeg blev. Selvfølgelig kommer det til at afhænge af en masse forskellige faktorer, men jeg tror virkelig, at Monsenso kan gøre en forskel. Mit håb er, at andre psykiatere og patienter også begynder at bruge app’en.

I Truly Believe Monsenso Can Help Others with Bipolar Disorder Type 2

I Truly Believe Monsenso Can Help Others with Bipolar Disorder Type 2

Watch Peter Hagelund’s documentary series, ‘Jeg savner min sygdom’  on living with bipolar disorder type 2 here.

Click here to read this story in Danish.

Four years ago, I was diagnosed with bipolar disorder type 2.

For my whole life I had known that something was different about me. I had always struggled with depression and anxiety, and what eventually turned out to be hypomania. When I was 22 I had my first big depression episode and had to start taking anti depressant medications. However, it would take me six more years before I was officially diagnosed with bipolar disorder type 2.

The tricky thing about having the diagnosis of bipolar type 2 is that you are not experiencing the typical manic episode where you are over-energetic and nearly psychotic. Instead, you’re hypomanic, which means that you’re socially well functioning. You’re not psychotic. You actually feel really good. So the problem is that you don’t end up going to your psychiatrist saying that you feel too good. At least I didn’t.

The reason why my psychiatrist found out I was bipolar was because he couldn’t get me out of my depressions. At first, my psychiatrist diagnosed me with depression and ADD. But these diagnoses didn’t fit. When I didn’t have the right diagnosis, I still had my large mood swings, and a lot of anxiety. When I was diagnosed with the ‘right’ diagnosis, of bipolar disorder type 2, it actually felt really nice. A lot of things made sense. Suddenly I could see why I had felt how I had for most of my life.

I really believe that Monsenso could have helped my psychiatrist diagnose my disorder earlier, because the app  helps me to keep track of my mood and really helps me to become more aware of how I feel. Due to the app, every single day I have to pause and take a moment to think about how I’ve actually been doing before putting my answers in the app. After doing this, when I go to my psychiatrist we can together see how I’ve actually been. The good thing with the app is that my answer to how I’ve been is not only based on my memory but how I actually answered that day. Logging all of this information has helped my treatment. My psychiatrist and I can better plan how to avoid my future depressive or hypomanic episodes, because we can clearly identify when I am having mood swings.  

In August, my documentary about being bipolar aired on national danish television. The reactions have been overwhelming. So many people have messaged me, thanking me for talking about the disease. I had originally made the documentary so that people would not be ashamed about having the disease.  I think I have succeed.

My hope for the future is that people will be diagnosed earlier with the disease than me. Of course, that will take a lot of other factors, however I truly believe Monsenso is one of the things that can help. My hope is that other psychiatrists and patients alike will start using the app.

“mHealth for better mental health treatment” Kristoffer Södersten’s Customer Story

“mHealth for better mental health treatment” Kristoffer Södersten’s Customer Story

To turn on English subtitles, click on the ‘CC’ at the bottom of the video. 

Psychiatrist Kristoffer Södersten from PsykiatriResurs in Sweden shares his experience using the Monsenso mHealth solution.

How does the Monsenso mHealth solution encourage and empower better mental health treatment? 

Kristoffer explains how the Monsenso mHealth solution helps him to enhance and inform treatment. Specifically, the solution helps him to gain more relevant information about his patients, such as information that couldn’t have been obtained through the traditional method of verbal sessions. “It’s difficult to retrieve reliable and consistent data from each patient during a verbal consultation with them,” says Kristoffer.

Obtaining the right information is key for psychiatrists and psychologists to provide an accurate diagnosis 

“[The accuracy from a diagnosis obtained] from face-to-face consultation depends so much on factors like personal relations, how comfortable the patient is in the conversation, cultural background, etc. Therefore, [due to these factors] it can be very arbitrary about which diagnosis a patient receives. This diagnosis can depend on which clinician he meets, and these other factors.” says Kristoffer. The information gathered from the Monsenso Clinic can help to provide a consistent and clearer view of the patient’s mental health, to better inform a diagnosis.

Kristoffer finds the Monsenso mHealth solution to be particularly helpful in capturing relevant objective data. The solution provides a comprehensive and easily accessible overview of relevant patient data, such as day score, mood score, sleep and medication adherence. Moreover, overview of collected sensor data, such as physical activity, social activity, phone usage and voice features can also be provided. This objective data can help to supplement the subjective data provided during verbal therapy.

“The technology of Monsenso can help us to gather more objective data that – together with the subjective experience – provide a more holistic picture of the patient’s problems, to help provide a more accurate diagnosis and follow-up treatment in a totally different way,” says Kristoffer.

Monsenso mHealth solution is providing a visualization of a historical data, which in some cases can identify why the symptoms appear and help to prevent them.

“You can also use this tool to predict future psychological outcomes, which can help us intervene early and prevent relapse.”